相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Engineering precision nanoparticles for drug delivery
Michael J. Mitchell et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
Lipid Nanoparticles-From Liposomes to mRNA Vaccine Delivery, a Landscape of Research Diversity and Advancement
Rumiana Tenchov et al.
ACS NANO (2021)
Rational Design of Poly(disulfide)s as a Universal Platform for Delivery of CRISPR-Cas9 Machineries toward Therapeutic Genome Editing
Jiajing Guo et al.
ACS CENTRAL SCIENCE (2021)
Lipid nanoparticles for mRNA delivery
Xucheng Hou et al.
NATURE REVIEWS MATERIALS (2021)
Mesoporous Silica Nanoparticles for Drug Delivery
Miguel Manzano et al.
ADVANCED FUNCTIONAL MATERIALS (2020)
Stemming the tide of drug resistance in cancer
Asher Mullard
NATURE REVIEWS DRUG DISCOVERY (2020)
Synthetic amorphous silica nanoparticles: toxicity, biomedical and environmental implications
Jonas G. Croissant et al.
NATURE REVIEWS MATERIALS (2020)
Antibody Delivery for Intracellular Targets: Emergent Therapeutic Potential
Khushboo Singh et al.
BIOCONJUGATE CHEMISTRY (2019)
The current state and future directions of RNAi-based therapeutics
Ryan L. Setten et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Strategies, design, and chemistry in siRNA delivery systems
Yizhou Dong et al.
ADVANCED DRUG DELIVERY REVIEWS (2019)
Mitochondria-Targeting, Intracellular Delivery of Native Proteins Using Biodegradable Silica Nanoparticles
Peiyan Yuan et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2019)
A Multifunctional Biodegradable Nanocomposite for Cancer Theranostics
Jianrong Wu et al.
ADVANCED SCIENCE (2019)
Rational Design of Nanocarriers for Intracellular Protein Delivery
Xiaofei Qin et al.
ADVANCED MATERIALS (2019)
Rekindling RNAi Therapy: Materials Design Requirements for In Vivo siRNA Delivery
Byungji Kim et al.
ADVANCED MATERIALS (2019)
A biodegradable nanocapsule delivers a Cas9 ribonucleoprotein complex for in vivo genome editing
Guojun Chen et al.
NATURE NANOTECHNOLOGY (2019)
A view on drug resistance in cancer
Neil Vasan et al.
NATURE (2019)
Smart cancer nanomedicine
Roy van der Meel et al.
NATURE NANOTECHNOLOGY (2019)
Nanoparticles-Mediated Combination Therapies for Cancer Treatment
Binita Shrestha et al.
ADVANCED THERAPEUTICS (2019)
Mesoporous Silica and Organosilica Nanoparticles: Physical Chemistry, Biosafety, Delivery Strategies, and Biomedical Applications
Jonas G. Croissant et al.
ADVANCED HEALTHCARE MATERIALS (2018)
Biodegradable Hollow Mesoporous Organosilica Nanotheranostics for Mild Hyperthermia-Induced Bubble-Enhanced Oxygen-Sensitized Radiotherapy
Nan Lu et al.
ACS NANO (2018)
Sustained delivery of siRNA/mesoporous silica nanoparticle complexes from nanofiber scaffolds for long-term gene silencing
Coline Pinese et al.
ACTA BIOMATERIALIA (2018)
Extra-Large Pore Mesoporous Silica Nanoparticles Enabling Co-Delivery of High Amounts of Protein Antigen and Toll-like Receptor 9 Agonist for Enhanced Cancer Vaccine Efficacy
Bong Geun Cha et al.
ACS CENTRAL SCIENCE (2018)
RNAi-Mediated β-Catenin Inhibition Promotes T Cell Infiltration and Antitumor Activity in Combination with Immune Checkpoint Blockade
Shanthi Ganesh et al.
MOLECULAR THERAPY (2018)
Bypassing Endocytosis: Direct Cytosolic Delivery of Proteins
Shubo Du et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2018)
Advances in mesoporous silica-based nanocarriers for co-delivery and combination therapy against cancer
Rafael R. Castillo et al.
EXPERT OPINION ON DRUG DELIVERY (2017)
Combine and conquer: challenges for targeted therapy combinations in early phase trials
Juanita S. Lopez et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Chemophototherapy: An Emerging Treatment Option for Solid Tumors
Dandan Luo et al.
ADVANCED SCIENCE (2017)
Overcoming cellular barriers for RNA therapeutics
Steven F. Dowdy
NATURE BIOTECHNOLOGY (2017)
Simultaneous Imaging of Endogenous Survivin mRNA and On-Demand Drug Release in Live Cells by Using a Mesoporous Silica Nanoquencher
Peiyan Yuan et al.
SMALL (2017)
Convergent Akt activation drives acquired EGFR inhibitor resistance in lung cancer
Kirstine Jacobsen et al.
NATURE COMMUNICATIONS (2017)
Intracellular Delivery of Functional Native Antibodies under Hypoxic Conditions by Using a Biodegradable Silica Nanoquencher
Peiyan Yuan et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2017)
A Suite of Minimalist Photo-Crosslinkers for Live-Cell Imaging and Chemical Proteomics: Case Study with BRD4 Inhibitors
Sijun Pan et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2017)
Redox-Responsive and Drug-Embedded Silica Nanoparticles with Unique Self-Destruction Features for Efficient Gene/Drug Codelivery
Qing Zhang et al.
ADVANCED FUNCTIONAL MATERIALS (2017)
A High-Throughput Platform for Formulating and Screening Multifunctional Nanoparticles Capable of Simultaneous Delivery of Genes and Transcription Factors
Yang Liu et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
Breakable Hybrid Organosilica Nanocapsules for Protein Delivery
Eko Adi Prasetyanto et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
Matrices for combined delivery of proteins and synthetic molecules
Kelly A. Gilmore et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Recent advances of cocktail chemotherapy by combination drug delivery systems
Quanyin Hu et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Opportunities and challenges in combination gene cancer therapy
Kent L. Nastiuk et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Co-delivery of chemotherapeutics and proteins for synergistic therapy
Chaoliang He et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Efficient delivery of genome-editing proteins using bioreducible lipid nanoparticles
Ming Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Coming-of-Age of Antibodies in Cancer Therapeutics
B. Vijayalakshmi Ayyar et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2016)
Intracellular Delivery of Functional Proteins and Native Drugs by Cell-Penetrating Poly(disulfide)s
Jiaqi Fu et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2015)
Cancer nanomedicine: from targeted delivery to combination therapy
Xiaoyang Xu et al.
TRENDS IN MOLECULAR MEDICINE (2015)
Systematic evaluation of antibody-mediated siRNA delivery using an industrial platform of THIOMAB-siRNA conjugates
Trinna L. Cuellar et al.
NUCLEIC ACIDS RESEARCH (2015)
Nanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: Current progress and advances
Nishant S. Gandhi et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Stimuli-sensitive nanopreparations for combination cancer therapy
Aditi Jhaveri et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Cellular Uptake of Substrate-Initiated Cell-Penetrating Poly(disulfide)s
Giulio Gasparini et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)
Nanoparticles for Combination Drug Therapy
Liang Ma et al.
ACS NANO (2013)
Nano-sized polymers and liposomes designed to deliver combination therapy for cancer
Anat Eldar-Boock et al.
CURRENT OPINION IN BIOTECHNOLOGY (2013)
Site-Specific Antibody-Polymer Conjugates for siRNA Delivery
Hua Lu et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2013)
Cancer drug resistance: an evolving paradigm
Caitriona Holohan et al.
NATURE REVIEWS CANCER (2013)
Nanoparticle-based combination therapy toward overcoming drug resistance in cancer
Che-Ming Jack Hu et al.
BIOCHEMICAL PHARMACOLOGY (2012)
Targeting the epidermal growth factor receptor in non-small cell lung cancer cells: the effect of combining RNA interference with tyrosine kinase inhibitors or cetuximab
Gang Chen et al.
BMC MEDICINE (2012)
Co-delivery of siRNA and therapeutic agents using nanocarriers to overcome cancer resistance
Mar Creixell et al.
NANO TODAY (2012)
Combination therapy: the next opportunity and challenge of medicine
Paolo A. Ascierto et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
Monoclonal antibodies: versatile platforms for cancer immunotherapy
Louis M. Weiner et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Nanoparticle therapeutics: an emerging treatment modality for cancer
Mark E. Davis et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Protein therapeutics: A summary and pharmacological classification
Benjamin Leader et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Targeting EGFR in colorectal cancer
Wells A. Messersmith et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Suppression of cervical carcinoma cell growth by intracytoplasmic codelivery of anti-oncoprotein E6 antibody and small interfering RNA
Jerome Courtete et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Epidermal growth factor receptor (EGFR) antibody down-regulates mutant receptors and inhibits tumors expressing EGFR mutations
Marianela Perez-Torres et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors
EW Song et al.
NATURE BIOTECHNOLOGY (2005)
分享论文
